1
|
Wan B, Patel M, Zhou G, Olma M, Bieri M, Mueller M, Appiah-Amponsah E, Patel B, Jayapal K. Robust platform for inline Raman monitoring and control of perfusion cell culture. Biotechnol Bioeng 2024; 121:1688-1701. [PMID: 38393313 DOI: 10.1002/bit.28680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/23/2024] [Accepted: 02/12/2024] [Indexed: 02/25/2024]
Abstract
Perfusion cell culture has been gaining increasing popularity for biologics manufacturing due to benefits such as smaller footprint, increased productivity, consistent product quality and manufacturing flexibility, cost savings, and so forth. Process Analytics Technologies tools are highly desirable for effective monitoring and control of long-running perfusion processes. Raman has been widely investigated for monitoring and control of traditional fed batch cell culture process. However, implementation of Raman for perfusion cell culture has been very limited mainly due to challenges with high-cell density and long running times during perfusion which cause extremely high fluorescence interference to Raman spectra and consequently it is exceedingly difficult to develop robust chemometrics models. In this work, a platform based on Raman measurement of permeate has been proposed for effective analysis of perfusion process. It has been demonstrated that this platform can effectively circumvent the fluorescence interference issue while providing rich and timely information about perfusion dynamics to enable efficient process monitoring and robust bioreactor feed control. With the highly consistent spectral data from cell-free sample matrix, development of chemometrics models can be greatly facilitated. Based on this platform, Raman models have been developed for good measurement of several analytes including glucose, lactate, glutamine, glutamate, and permeate titer. Performance of Raman models developed this way has been systematically evaluated and the models have shown good robustness against changes in perfusion scale and variations in permeate flowrate; thus models developed from small lab scale can be directly transferred for implementation in much larger scale of perfusion. With demonstrated robustness, this platform provides a reliable approach for automated glucose feed control in perfusion bioreactors. Glucose model developed from small lab scale has been successfully implemented for automated continuous glucose feed control of perfusion cell culture at much larger scale.
Collapse
Affiliation(s)
- Boyong Wan
- Analytical Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Misaal Patel
- Bioprocess Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - George Zhou
- Global Vaccine and Biologics Commercialization, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Michael Olma
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | - Marco Bieri
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | - Marvin Mueller
- Analytical Research & Development, Werthenstein Biopharma GmbH, MSD, Werthenstein, Switzerland
| | | | - Bhumit Patel
- Analytical Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| | - Karthik Jayapal
- Bioprocess Research & Development, Merck & Co. Inc., Kenilworth, New Jersey, USA
| |
Collapse
|
2
|
Müller DH, Börger M, Thien J, Koß HJ. Bioprocess in-line monitoring and control using Raman spectroscopy and Indirect Hard Modeling (IHM). Biotechnol Bioeng 2024. [PMID: 38678541 DOI: 10.1002/bit.28724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Revised: 01/27/2024] [Accepted: 04/12/2024] [Indexed: 05/01/2024]
Abstract
Process in-line monitoring and control are crucial to optimize the productivity of bioprocesses. A frequently applied Process Analytical Technology (PAT) tool for bioprocess in-line monitoring is Raman spectroscopy. However, evaluating bioprocess Raman spectra is complex and calibrating state-of-the-art statistical evaluation models is effortful. To overcome this challenge, we developed an Indirect Hard Modeling (IHM) prediction model in a previous study. The combination of Raman spectroscopy and the IHM prediction model enables non-invasive in-line monitoring of glucose and ethanol mass fractions during yeast fermentations with significantly less calibration effort than comparable approaches based on statistical models. In this study, we advance this IHM-based approach and successfully demonstrate that the combination of Raman spectroscopy and IHM is capable of not only bioprocess monitoring but also bioprocess control. For this purpose, we used this combination's in-line information as input of a simple on-off glucose controller to control the glucose mass fraction in Saccharomyces cerevisiae fermentations. When we performed two of these fermentations with different predefined glucose set points, we achieved similar process control quality as approaches using statistical models, despite considerably smaller calibration effort. Therefore, this study reaffirms that the combination of Raman spectroscopy and IHM is a powerful PAT tool for bioprocesses.
Collapse
Affiliation(s)
| | - Marieke Börger
- Institute of Technical Thermodynamics, RWTH Aachen University, Aachen, Germany
| | - Julia Thien
- Institute of Technical Thermodynamics, RWTH Aachen University, Aachen, Germany
| | - Hans-Jürgen Koß
- Institute of Technical Thermodynamics, RWTH Aachen University, Aachen, Germany
| |
Collapse
|
3
|
Westwood F, Ponstingl M, Dickens JE. Analytical figures of merit of a dual-wavelength absorbance approach for real-time broad protein content monitoring for biomanufacturing. J Pharm Biomed Anal 2024; 241:115965. [PMID: 38237541 DOI: 10.1016/j.jpba.2024.115965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 12/21/2023] [Accepted: 01/04/2024] [Indexed: 02/21/2024]
Abstract
Real-time in-line broad protein content monitoring in biomanufacturing downstream unit operations enables the ability to optimize and afford consistent protein recovery. Protein determination from 2 to 400 mg/mL is demonstrated herein via real-time dual-wavelength LED photometric sensor configured at 280 and 310 nm. The figures of merit of this approach include measurement accuracy within the common acceptance criteria of 100 % ± 5 with negligible bias across the linear dynamic ranges. This work expands the utility of an LED based photometric sensor for biopharmaceutical process analytical technology (PAT) applications. It is also congruent with process digitalization and automation industry 4.0 concepts underpinned by Quality by Design (QbD) principles.
Collapse
Affiliation(s)
- Frank Westwood
- Custom Sensors and Technology Inc., 531 Axminister Dr, Fenton, MO 63026, USA
| | - Michael Ponstingl
- Custom Sensors and Technology Inc., 531 Axminister Dr, Fenton, MO 63026, USA
| | - Jason E Dickens
- Custom Sensors and Technology Inc., 531 Axminister Dr, Fenton, MO 63026, USA.
| |
Collapse
|
4
|
Dekevic G, Tertel T, Tasto L, Schmidt D, Giebel B, Czermak P, Salzig D. A Bioreactor-Based Yellow Fever Virus-like Particle Production Process with Integrated Process Analytical Technology Based on Transient Transfection. Viruses 2023; 15:2013. [PMID: 37896790 PMCID: PMC10612092 DOI: 10.3390/v15102013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2023] [Revised: 09/21/2023] [Accepted: 09/22/2023] [Indexed: 10/29/2023] Open
Abstract
Yellow Fever (YF) is a severe disease that, while preventable through vaccination, lacks rapid intervention options for those already infected. There is an urgent need for passive immunization techniques using YF-virus-like particles (YF-VLPs). To address this, we successfully established a bioreactor-based production process for YF-VLPs, leveraging transient transfection and integrating Process Analytical Technology. A cornerstone of this approach was the optimization of plasmid DNA (pDNA) production to a yield of 11 mg/L using design of experiments. Glucose, NaCl, yeast extract, and a phosphate buffer showed significant influence on specific pDNA yield. The preliminary work for VLP-production in bioreactor showed adjustments to the HEK cell density, the polyplex formation duration, and medium exchanges effectively elevated transfection efficiencies. The additive Pluronic F-68 was neutral in its effects, and anti-clumping agents (ACA) adversely affected the transfection process. Finally, we established the stirred-tank bioreactor process with integrated dielectric spectroscopy, which gave real-time insight in relevant process steps, e.g., cell growth, polyplex uptake, and harvest time. We confirmed the presence and integrity of YF-VLP via Western blot, imaging flow cytometry measurement, and transmission electron microscopy. The YF-VLP production process can serve as a platform to produce VLPs as passive immunizing agents against other neglected tropical diseases.
Collapse
Affiliation(s)
- Gregor Dekevic
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| | - Tobias Tertel
- Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Virchowstrasse 179, 45147 Essen, Germany; (T.T.); (B.G.)
| | - Lars Tasto
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| | - Deborah Schmidt
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| | - Bernd Giebel
- Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Virchowstrasse 179, 45147 Essen, Germany; (T.T.); (B.G.)
| | - Peter Czermak
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
- Faculty of Biology and Chemistry, University of Giessen, Heinrich-Buff-Ring 17, 35392 Giessen, Germany
| | - Denise Salzig
- Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstrasse 14, 35390 Giessen, Germany; (G.D.); (L.T.); (D.S.); (P.C.)
| |
Collapse
|
5
|
Madarász L, Alexandra Mészáros L, Köte Á, Farkas A, Kristóf Nagy Z. AI-based Analysis of In-line Process Endoscope images for Real-time Particle Size Measurement in a Continuous Pharmaceutical Milling Process. Int J Pharm 2023; 641:123060. [PMID: 37209791 DOI: 10.1016/j.ijpharm.2023.123060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Revised: 05/12/2023] [Accepted: 05/13/2023] [Indexed: 05/22/2023]
Abstract
This paper presents a case study on the first in-line application of AI-based image analysis for real-time pharmaceutical particle size measurement in a continuous milling process. An AI-based imaging system, which utilises a rigid endoscope, was tested for the real-time particle size measurement of solid NaCl powder used as a model API in the range of 200-1000µm. After creating a dataset containing annotated images of NaCl particles, it was used to train an AI model for detecting particles and measuring their size. The developed system could analyse overlapping particles without dispersing air, thus broadening its applicability. The performance of the system was evaluated by measuring pre-sifted NaCl samples with the imaging tool, after which it was installed into a continuous mill for in-line particle size measurement of a milling process. By analysing ∼100 particles/s, the system was able to accurately measure the particle size of sifted NaCl samples and detect particle size reduction when applied in the milling process. The Dv50 values and PSDs measured real-time with the AI-based system correlated well with the reference laser diffraction measurements (<6% mean absolute difference over the measured samples). The AI-based imaging system shows great potential for in-line particle size analysis, which, in line with the latest pharmaceutical QC trends, can provide valuable information for process development and control.
Collapse
Affiliation(s)
- Lajos Madarász
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| | - Lilla Alexandra Mészáros
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| | - Ákos Köte
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| | - Attila Farkas
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| | - Zsombor Kristóf Nagy
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary.
| |
Collapse
|
6
|
Müller DH, Flake C, Brands T, Koß HJ. Bioprocess in-line monitoring using Raman spectroscopy and Indirect Hard Modeling (IHM): A simple calibration yields a robust model. Biotechnol Bioeng 2023. [PMID: 37166028 DOI: 10.1002/bit.28424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Revised: 04/12/2023] [Accepted: 04/29/2023] [Indexed: 05/12/2023]
Abstract
To increase the process productivity and product quality of bioprocesses, the in-line monitoring of critical process parameters is highly important. For monitoring substrate, metabolite, and product concentrations, Raman spectroscopy is a commonly used Process Analytical Technology (PAT) tool that can be applied in-situ and non-invasively. However, evaluating bioprocess Raman spectra with a robust state-of-the-art statistical model requires effortful model calibration. In the present study, we in-line monitored a glucose to ethanol fermentation by Saccharomyces cerevisiae (S. cerevisiae) using Raman spectroscopy in combination with the physics-based Indirect Hard Modeling (IHM) and showed successfully that IHM is an alternative to statistical models with significantly lower calibration effort. The IHM prediction model was developed and calibrated with only 16 Raman spectra in total, which did not include any process spectra. Nevertheless, IHM's root mean square errors of prediction (RMSEPs) for glucose (3.68 g/L) and ethanol (1.69 g/L) were comparable to the prediction quality of similar studies that used statistical models calibrated with several calibration batches. Despite our simple calibration, we succeeded in developing a robust model for evaluating bioprocess Raman spectra.
Collapse
Affiliation(s)
| | - Carsten Flake
- Institute of Technical Thermodynamics, RWTH Aachen University, Aachen, Germany
- Energy and Process Systems Engineering, ETH Zurich, Zurich, Switzerland
| | - Thorsten Brands
- Institute of Technical Thermodynamics, RWTH Aachen University, Aachen, Germany
| | - Hans-Jürgen Koß
- Institute of Technical Thermodynamics, RWTH Aachen University, Aachen, Germany
| |
Collapse
|
7
|
Simão J, Chaudhary SA, Ribeiro AJ. Implementation of Quality by Design (QbD) for development of bilayer tablets. Eur J Pharm Sci 2023; 184:106412. [PMID: 36828037 DOI: 10.1016/j.ejps.2023.106412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 02/20/2023] [Accepted: 02/20/2023] [Indexed: 02/25/2023]
Abstract
Bilayer tablets offer various drug release profiles for individual drugs incorporated in each layer of a bilayer tablet, which is rarely achievable by conventional tablets. These tablets also help avoid physicochemical incompatibilities between drugs and excipients. Successful manufacturing of such more complex dosage forms depends upon screening of material attributes of API and excipients as well as optimization of processing parameters of individual unit operations of the manufacturing process that must be strictly monitored and controlled to obtain an acceptable drug product quality and performance in order to achieve safety and efficacy per regulatory requirements. Optimizing formulation attributes and manufacturing processes during critical stages, such as blending, granulation, pre-compression, and main compression, can help avoid problems such as weight variation, segregation, and delamination of individual layers, which are frequently faced during the production of bilayer tablets. The main objective of this review is to establish the basis for the implementation of Quality by Design (QbD) system principles for the design and development of bilayer tablets, encompassing the preliminary and systematic risk assessment of critical material attributes (CMAs) and critical process parameters (CPPs) with respect to in-process and finished product critical quality attributes (CQAs). Moreover, the applicability of the QbD methodology based on its purpose is discussed and complemented with examples of bilayer tablet technology.
Collapse
Affiliation(s)
- J Simão
- Faculdade de Farmácia, Universidade de Coimbra, Coimbra, Portugal
| | - S A Chaudhary
- National Institute of Pharmaceutical Education and Research, Ahmedabad, India
| | - A J Ribeiro
- Faculdade de Farmácia, Universidade de Coimbra, Coimbra, Portugal; i3S, IBMC, Rua Alfredo Allen, Porto, Portugal.
| |
Collapse
|
8
|
São Pedro MN, Santos MS, Eppink MHM, Ottens M. Design of a microfluidic mixer channel: First steps into creating a fluorescent dye-based biosensor for mAb aggregate detection. Biotechnol J 2023; 18:e2200332. [PMID: 36330557 DOI: 10.1002/biot.202200332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2022] [Revised: 08/29/2022] [Accepted: 09/06/2022] [Indexed: 11/06/2022]
Abstract
A major challenge in the transition to continuous biomanufacturing is the lack of process analytical technology (PAT) tools which are able to collect real-time information on the process and elicit a response to facilitate control. One of the critical quality attributes (CQAs) of interest during monoclonal antibodies production is aggregate formation. The development of a real-time PAT tool to monitor aggregate formation is then crucial to have immediate feedback and process control. Miniaturized sensors placed after each unit operation can be a powerful solution to speed up an analytical measurement due to their characteristic short reaction time. In this work, a micromixer structure capable of mixing two streams is presented, to be employed in the detection of mAb aggregates using fluorescent dyes. Computational fluid dynamics (CFD) simulations were used to compare the mixing performance of a series of the proposed designs. A final design of a zigzag microchannel with 45° angle was reached and this structure was subsequently fabricated and experimentally validated with colour dyes and, later, with a FITC-IgG molecule. The designed zigzag micromixer presents a mixing index of around 90%, obtained in less than 30 seconds. Therefore, a micromixer channel capable of a fast and efficient mixing is hereby demonstrated, to be used as a real-time PAT tool for a fluorescence based detection of protein aggregation.
Collapse
Affiliation(s)
- Mariana N São Pedro
- Department of Biotechnology, Delft University of Technology, Delft, the Netherlands
| | - Mafalda S Santos
- Department of Biotechnology, Delft University of Technology, Delft, the Netherlands
| | - Michel H M Eppink
- Byondis B.V., Nijmegen, the Netherlands.,Bioprocessing Engineering, Wageningen University, Wageningen, the Netherlands
| | - Marcel Ottens
- Department of Biotechnology, Delft University of Technology, Delft, the Netherlands
| |
Collapse
|
9
|
Madarász L, Köte Á, Hambalkó B, Csorba K, Kovács V, Lengyel L, Marosi G, Farkas A, Nagy ZK, Domokos A. In-line particle size measurement based on image analysis in a fully continuous granule manufacturing line for rapid process understanding and development. Int J Pharm 2022; 612:121280. [PMID: 34774695 DOI: 10.1016/j.ijpharm.2021.121280] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Revised: 10/27/2021] [Accepted: 11/06/2021] [Indexed: 12/01/2022]
Abstract
The present paper serves as a demonstration how an in-line PAT tool can be used for rapid and efficient process development in a fully continuous powder to granule line consisting of an interconnected twin-screw wet granulator, vibrational fluid bed dryer, and a regranulating mill. A new method was investigated for the periodic in-line particle size measurement of high mass flow materials to obtain real-time particle size data of the regranulated product. The system utilises a vibratory feeder with periodically altered feeding intensity in order to temporarily reduce the mass flow of the material passing in front of the camera. This results in the drastic reduction of particle overlapping in the images, making image analysis a viable tool for the in-line particle size measurement of high mass-flow materials. To evaluate the performance of the imaging system, the effect of several milling settings and the liquid-to-solid ratio was investigated on the product's particle size in the span of a few hours. The particle sizes measured with the in-line system were in accordance with the expected trends as well as with the results of the off-line reference particle size measurements. Based on the results, the in-line imaging system can serve as a PAT tool to obtain valuable real-time information for rapid process development or quality assurance.
Collapse
Affiliation(s)
- Lajos Madarász
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| | - Ákos Köte
- Department of Automation and Applied Informatics, Budapest University of Technology and Economics, H-1117, Budapest Magyar Tudósok körútja 2 QB-207, Hungary
| | - Bence Hambalkó
- Department of Automation and Applied Informatics, Budapest University of Technology and Economics, H-1117, Budapest Magyar Tudósok körútja 2 QB-207, Hungary
| | - Kristóf Csorba
- Department of Automation and Applied Informatics, Budapest University of Technology and Economics, H-1117, Budapest Magyar Tudósok körútja 2 QB-207, Hungary
| | - Viktor Kovács
- Department of Automation and Applied Informatics, Budapest University of Technology and Economics, H-1117, Budapest Magyar Tudósok körútja 2 QB-207, Hungary
| | - László Lengyel
- Department of Automation and Applied Informatics, Budapest University of Technology and Economics, H-1117, Budapest Magyar Tudósok körútja 2 QB-207, Hungary
| | - György Marosi
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| | - Attila Farkas
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| | - Zsombor Kristóf Nagy
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary.
| | - András Domokos
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary
| |
Collapse
|
10
|
Gerzon G, Sheng Y, Kirkitadze M. Process Analytical Technologies - Advances in bioprocess integration and future perspectives. J Pharm Biomed Anal 2022; 207:114379. [PMID: 34607168 DOI: 10.1016/j.jpba.2021.114379] [Citation(s) in RCA: 21] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 09/12/2021] [Accepted: 09/15/2021] [Indexed: 12/22/2022]
Abstract
Process Analytical Technology (PAT) instruments include analyzers capable of measuring physical and chemical process parameters and key attributes with the goal of optimizing process controls. PAT in the form of a probe or sensor is designed to integrate within the pharmaceutical manufacturing line and is coupled with computing equipment to perform chemometric modeling for result interpretation and multilayer statistical control of processes. PAT solutions are intended for understanding bioprocesses with a goal to control quality at all stages of product manufacturing and achieve quality by design (QbD). The goal of PAT implementation is to promote real-time release of products to decrease the cycle time and cost of production. This review focuses on the applications of PAT solutions at different stages of the manufacturing process for vaccine production, the advantages, challenges at present state, and the vision of the future development of biopharmaceutical industries.
Collapse
Affiliation(s)
- Gabriella Gerzon
- Department of Biology, Faculty of Science, York University, Toronto, Canada; Analytical Sciences, Sanofi Pasteur, Toronto, Canada
| | - Yi Sheng
- Department of Biology, Faculty of Science, York University, Toronto, Canada
| | | |
Collapse
|
11
|
Wu S, Ketcham SA, Corredor CC, Both D, Drennen JK, Anderson CA. Rapid At-line Early Cell Death Quantification using Capacitance Spectroscopy. Biotechnol Bioeng 2021; 119:857-867. [PMID: 34927241 DOI: 10.1002/bit.28011] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Revised: 12/03/2021] [Accepted: 12/06/2021] [Indexed: 11/10/2022]
Abstract
Cell death is one of the failure modes of mammalian cell culture. Apoptosis is a regulated cell death process mainly observed in cell culture. Timely detection of apoptosis onset allows opportunities for preventive controls that ensure high productivity and consistent product quality. Capacitance spectroscopy captures the apoptosis-related cellular properties changes and thus quantifies the percentage of dying cells. This work demonstrated a quantification model that measures the percentage of apoptotic cells using a capacitance spectrometer in an at-line setup. When predicting the independent test set collected from bench-scale bioreactors, the root-mean-squared error of prediction (RMSEP) was 8.8% (equivalent to 9.9% of the prediction range). The predicted culture evolution trajectory aligned with measured values from the flow cytometer. Furthermore, this method alarms cell death onset earlier than the traditional viability test, i.e., trypan blue exclusion test. Comparing to flow cytometry (the traditional early cell death detection method), this method is rapid, simple, and less labor-intensive. Additionally, this at-line setup can be easily transferred between scales (e.g., lab-scale for development to manufacturing-scale), which benefits process transfers between facilities, scale-up, and other process transitions. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Suyang Wu
- Duquesne Center for Pharmaceutical Technology, Duquesne University, Pittsburgh, Pennsylvania, 15282.,Duquesne University Graduate School for Pharmaceutical Sciences, Pittsburgh, Pennsylvania, 15282
| | - Stephanie A Ketcham
- Manufacutring Science and Technology, Bristol-Myers Squibb, Devens, Massachusetts, 01434
| | - Claudia C Corredor
- Pharmaceutical Development, Bristol-Myers Squibb, New Brunswick, New Jersey, 08903
| | - Douglas Both
- Pharmaceutical Development, Bristol-Myers Squibb, New Brunswick, New Jersey, 08903
| | - James K Drennen
- Duquesne Center for Pharmaceutical Technology, Duquesne University, Pittsburgh, Pennsylvania, 15282.,Duquesne University Graduate School for Pharmaceutical Sciences, Pittsburgh, Pennsylvania, 15282
| | - Carl A Anderson
- Duquesne Center for Pharmaceutical Technology, Duquesne University, Pittsburgh, Pennsylvania, 15282.,Duquesne University Graduate School for Pharmaceutical Sciences, Pittsburgh, Pennsylvania, 15282
| |
Collapse
|
12
|
Rodrigues CP, Duchesne C, Poulin É, Lapointe-Garant PP. In-line cosmetic end-point detection of batch coating processes for colored tablets using multivariate image analysis. Int J Pharm 2021; 606:120953. [PMID: 34329698 DOI: 10.1016/j.ijpharm.2021.120953] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Revised: 07/23/2021] [Accepted: 07/25/2021] [Indexed: 11/16/2022]
Abstract
In this study, an in-line Process Analytical Technology (PAT) for cosmetic (non-functional) coating unit operations is developed using images of the tablet bed acquired in real-time by an inexpensive industrial camera and lighting system. The cosmetic end-point of multiple batches, run under different operating conditions, is automatically computed from these images using a Multivariate Image Analysis (MIA) methodology in conjunction with a stability determination strategy. The end-points detected by the algorithm differed, on average, by 3% in terms of total batch time from those identified visually by a trained operator. Since traditional practice typically relies on a coating overage to ensure full batch aspect homogeneity in the face of disturbances, the current in-line method can be used to reduce coating material and processing time (over 40% for the operating policy adopted in this work). Additionally, monitoring of the color features calculated by the algorithm allowed the identification of abnormal process conditions affecting visible coating uniformity. This work also addresses practical challenges related to image acquisition in the harsh environment of a pan coater, bringing this tool closer to a state of maturity for implementation in production units and opening the path for their optimization, monitoring, and automatic control.
Collapse
Affiliation(s)
- Cecilia Pereira Rodrigues
- Laboratoire d'observation et d'optimisation des procédés (LOOP), Université Laval, Pavillon Adrien-Pouliot Québec (Québec), G1V 0A6, Canada
| | - Carl Duchesne
- Laboratoire d'observation et d'optimisation des procédés (LOOP), Université Laval, Pavillon Adrien-Pouliot Québec (Québec), G1V 0A6, Canada.
| | - Éric Poulin
- Laboratoire d'observation et d'optimisation des procédés (LOOP), Université Laval, Pavillon Adrien-Pouliot Québec (Québec), G1V 0A6, Canada
| | | |
Collapse
|
13
|
Stranzinger S, Wolfgang M, Klotz E, Scheibelhofer O, Ghiotti P, Khinast JG, Hsiao WK, Paudel A. Near-Infrared Hyperspectral Imaging as a Monitoring Tool for On-Demand Manufacturing of Inkjet-Printed Formulations. AAPS PharmSciTech 2021; 22:211. [PMID: 34374899 PMCID: PMC8354920 DOI: 10.1208/s12249-021-02091-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Accepted: 07/08/2021] [Indexed: 12/02/2022] Open
Abstract
This study evaluates the potential use of near-infrared hyperspectral imaging (NIR-HSI) for quantitative determination of the drug amount in inkjet-printed dosage forms. We chose metformin hydrochloride as a model active pharmaceutical ingredient (API) and printed it onto gelatin films using a piezoelectric inkjet printing system. An industry-ready NIR-HSI sensor combined with a motorized movable linear stage was applied for spectral acquisition. Initial API-substrate screening revealed best printing results for gelatin films with TiO2 filling. For calibration of the NIR-HSI system, escalating drug doses were printed on the substrate. After spectral pre-treatments, including standard normal variate (SNV) and Savitzky-Golay filtering for noise reduction and enhancement of spectral features, principal component analysis (PCA) and partial least squares (PLS) regression were applied to create predictive models for the quantification of independent printed metformin hydrochloride samples. It could be shown that the concentration distribution maps provided by the developed HSI models were capable of clustering and predicting the drug dose in the formulations. HSI model prediction showed significant better correlation to the reference (HPLC) compared to on-board monitoring of dispensed volume of the printer. Overall, the results emphasize the capability of NIR-HSI as a fast and non-destructive method for the quantification and quality control of the deposited API in drug-printing applications.
Collapse
|
14
|
Biagi D, Nencioni P, Valleri M, Calamassi N, Mura P. Development of a Near Infrared Spectroscopy method for the in-line quantitative bilastine drug determination during pharmaceutical powders blending. J Pharm Biomed Anal 2021; 204:114277. [PMID: 34332309 DOI: 10.1016/j.jpba.2021.114277] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Revised: 07/13/2021] [Accepted: 07/21/2021] [Indexed: 11/28/2022]
Abstract
The Food and Drug Administration (FDA)'s guidelines and the Process Analytical Technology (PAT) approach conceptualize the idea of real time monitoring of a process, with the primary objective of improvement of quality and also of time and resources saving. New instruments are needed to perform an efficient PAT process control and Near Infrared Spectroscopy (NIRS), thanks to its rapid and drastic development of last years, could be a very good choice, in virtue of its high versatility, speed of analysis, non-destructiveness and absence of sample chemical treatment. This work was aimed to develop a NIR analytical method for bilastine assay in powder mixtures for direct compression. In particular, the use of NIR instrumentation should allow to control the bilastine concentration and the whole blending process, assuring the achievement of a homogeneous blend. The commercial tablet formulation of bilastine was particularly suitable for this purpose, due to its simple composition (four excipients) and direct compression manufacturing process. Calibration and validation set were prepared according to a Placket-Burman experimental design and acquired with a miniaturized NIR in-line instrument (MicroNIR by Viavi Solution Inc.). Chemometric was applied to optimize information extraction from spectra, by subjecting them to a Standard Normal Variate (SNV) and a Savitzky-Golay second derivative pre-treatment. This spectra pre-treatment, combined with the most suitable wavelength interval (resulted between 1087 and 1217 nm), enabled to obtain a Partial Least Square (PLS) model with a good predictive ability. The selected model, tried on laboratory and production batches, provided in both cases good assay predictions. Results were confirmed by traditional HPLC (High Performance Liquid Chromatography) API (Active Pharmaceutical Ingredient) content uniformity test on the final product.
Collapse
Affiliation(s)
- Diletta Biagi
- Menarini Manufacturing Logistic and Services s.r.l. (AMMLS), Via dei Sette Santi 1/3, 50131, Florence, Italy; Department of Chemistry, University of Florence, Via U. Schiff 6, 50019, Sesto Fiorentino, Florence, Italy.
| | - Paolo Nencioni
- Menarini Manufacturing Logistic and Services s.r.l. (AMMLS), Via dei Sette Santi 1/3, 50131, Florence, Italy
| | - Maurizio Valleri
- Menarini Manufacturing Logistic and Services s.r.l. (AMMLS), Via dei Sette Santi 1/3, 50131, Florence, Italy
| | - Niccolò Calamassi
- Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, 06123, Perugia, Italy
| | - Paola Mura
- Department of Chemistry, University of Florence, Via U. Schiff 6, 50019, Sesto Fiorentino, Florence, Italy
| |
Collapse
|
15
|
Eduardo DT, Ana SE, José B F. A micro-extrusion 3D printing platform for fabrication of orodispersible printlets for pediatric use. Int J Pharm 2021; 605:120854. [PMID: 34224841 DOI: 10.1016/j.ijpharm.2021.120854] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2021] [Revised: 06/29/2021] [Accepted: 06/30/2021] [Indexed: 01/21/2023]
Abstract
3D printed pharmaceuticals offers the potential to manufacture personalized medicines for patients. Such technology is of particular benefit to pediatric populations from the offer of increased patient compliance and dose flexibility. With a bench-to-patient approach, this study established and optimized the critical parameters of the semi-solid micro-extrusion 3D printing process to guarantee the quality attributes of the final dosage form. Pediatrics orodispersible printlets of hydrochlorothiazide were manufactured through the modification of printing parameters, as well as printing surfaces materials. The printlets were characterized and the dimensions were measured using a digital caliper and computer vision algorithm. This study identified that the printing surface material and the first printing layer are critical parameters for high-resolution printlets. Following the optimization of 3D printing parameters, high quality orodispersible printlets loaded with hydrochlorothiazide - specifically tailored for pediatric patient's dosage forms - were obtained (4.62 mm × 1.90 mm). Mass and content uniformity assays demonstrated that the printlets satisfied the requirements for orodispersible printlets set by the European Pharmacopoeia. As such, in order to transition from laboratory research towards the treatment of patients, distinguishing accurate 3D printing parameters is necessary for the manufacture of medicines with key quality attributes that follow Pharmacopoeia requirements.
Collapse
Affiliation(s)
- Díaz-Torres Eduardo
- Facultad de Farmacia, Universidad de La Laguna, La Laguna 38206, Spain; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, La Laguna 38206, Spain; Programa de Doctorado en Ciencias Médicas y Farmacéuticas, Desarrollo y Calidad de Vida, Universidad de La Laguna, 38200 La Laguna (Tenerife), Spain; Programa predoctoral de formación del personal investigador en Canarias, Consejería de Economía, Conocimiento y Empleo, Spain
| | - Santoveña-Estévez Ana
- Facultad de Farmacia, Universidad de La Laguna, La Laguna 38206, Spain; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, La Laguna 38206, Spain.
| | - Fariña José B
- Facultad de Farmacia, Universidad de La Laguna, La Laguna 38206, Spain; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, La Laguna 38206, Spain
| |
Collapse
|
16
|
Haer M, Strahlendorf K, Payne J, Jung R, Xiao E, Mirabel C, Rahman N, Kowal P, Gemmiti G, Cronin JT, Gable T, Park-Lee K, Drolet-Vives K, Balmer M, Kirkitadze M. PAT solutions to monitor adsorption of Tetanus Toxoid with aluminum adjuvants. J Pharm Biomed Anal 2021; 198:114013. [PMID: 33713883 DOI: 10.1016/j.jpba.2021.114013] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2021] [Revised: 03/03/2021] [Accepted: 03/04/2021] [Indexed: 11/28/2022]
Abstract
The focus of this study was to examine the small-scale adsorption process of Tetanus Toxoid (TT) as a model protein antigen to aluminum phosphate (AlPO4) and aluminum oxyhydroxide (AlOOH) adjuvants with real-time monitoring by in-line ReactIR™, ParticleTrack™ based on Focused Beam Reflectance Measurement (FBRM) and EasyViewer™ probes. The adsorption process of AlPO4 and AlOOH with TT using was monitored in the small-scale reactors. Conformational changes in TT were monitored using in-line infrared probe ReactIR, whereas particle formation associated with protein adsorption were measured by particle size, count, and imaging tools, such as ParticleTrack with FBRM and EasyViewer probes. ParticleTrack distribution results and kinetic measurements were also supported by observations made using EasyViewer. In addition to EasyMax, BioBLU reactor was also used for the adsorption experiments. ReactIR with ATR-Fiber probe was effectively able to monitor adsorption progress of TT to AlOOH and to AlPO4. ReactIR, EasyViewer, and ParticleTrack provided detailed mechanistic and kinetic information for reaction of TT with AlPO4 and AlOOH. These in-situ measurements revealed a possible multi-step process for TT to AlPO4 which may be an indication of antigen adsorption.
Collapse
Affiliation(s)
- Manjit Haer
- Analytical Sciences, Sanofi Pasteur, Toronto, Canada
| | | | - Jessie Payne
- Analytical Sciences, Sanofi Pasteur, Toronto, Canada
| | - Ryan Jung
- Bioprocess Research and Development, Sanofi Pasteur, Toronto, Canada
| | - Emily Xiao
- Bioprocess Research and Development, Sanofi Pasteur, Toronto, Canada
| | | | - Nausheen Rahman
- Bioprocess Research and Development, Sanofi Pasteur, Toronto, Canada
| | - Przemek Kowal
- Analytical Sciences, Sanofi Pasteur, Toronto, Canada
| | | | | | - Tyler Gable
- Mettler Toledo AutoChem Inc., Columbia, MD, USA
| | | | | | | | | |
Collapse
|
17
|
Hebbi V, Thakur G, Rathore AS. Process analytical technology application for protein PEGylation using near infrared spectroscopy: G-CSF as a case study. J Biotechnol 2020; 325:303-311. [PMID: 33039551 DOI: 10.1016/j.jbiotec.2020.10.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 09/15/2020] [Accepted: 10/06/2020] [Indexed: 11/25/2022]
Abstract
Conjugation of protein therapeutics with polymers like polyethylene glycol (PEG) has been shown to increase their therapeutic efficiency. However, manufacturing of PEGylated drugs requires an additional, carefully controlled reaction step after purifying the protein, followed by further purification of over- and under-PEGylated variants. In this work, we have used a combined spectroscopic and statistical approach for monitoring and control of the PEGylation reaction for G-CSF using near infrared spectroscopy (NIRS). An online NIRS probe deployed in the reaction vessel has been used to track conversion of G-CSF into monoPEGylated and multiPEGylated forms using calibrated partial least squares regression models on the NIRS spectra which are collected in real time every 3 s. A pH probe integrated with a peristaltic pump facilitates automated quenching of the reaction at the targeted time. The NIRS spectra have also been used to build a batch evolution model for the reaction from end-to-end, including the addition of the reactants to the reaction vessel, the progress of the reaction for 70 min, and the final quenching with Tris base. Online spectra are compared against the statistical process control charts of the batch evolution model in real time to detect deviations as soon as they occur. The system was demonstrated for four common deviations in the PEGylation process, namely: delayed quenching time, wrong concentration of reducing agent added, wrong PEG to G-CSF ratio, and wrong sequence of addition of reactants. The system was able to identify all four deviations in real time and alert the operator to take control actions. The PAT approach suggested here embraces the quality by design framework and can be generalized for manufacturing scale monitoring and control of different biotechnology reactions with spectroscopic signatures.
Collapse
Affiliation(s)
- Vishwanath Hebbi
- Department of Chemical Engineering, Indian Institute of Technology, 110016, Hauz Khas, India
| | - Garima Thakur
- Department of Chemical Engineering, Indian Institute of Technology, 110016, Hauz Khas, India
| | - Anurag S Rathore
- Department of Chemical Engineering, Indian Institute of Technology, 110016, Hauz Khas, India.
| |
Collapse
|
18
|
Schlindwein W, Bezerra M, Almeida J, Berghaus A, Owen M, Muirhead G. In-Line UV-Vis Spectroscopy as a Fast-Working Process Analytical Technology (PAT) during Early Phase Product Development Using Hot Melt Extrusion (HME). Pharmaceutics 2018; 10:E166. [PMID: 30249025 DOI: 10.3390/pharmaceutics10040166] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2018] [Revised: 09/04/2018] [Accepted: 09/11/2018] [Indexed: 11/28/2022] Open
Abstract
This paper displays the potential of an in-line PAT system for early phase product development during pharmaceutical continuous manufacturing following a Quality by Design (QbD) framework. Hot melt extrusion (HME) is used as continuous manufacturing process and UV–Vis spectroscopy as an in-line monitoring system. A sequential design of experiments (DoE) (screening, optimisation and verification) was used to gain process understanding for the manufacture of piroxicam (PRX)/Kollidon® VA64 amorphous solid dispersions. The influence of die temperature, screw speed, solid feed rate and PRX concentration on the critical quality attributes (CQAs) absorbance and lightness of color (L*) of the extrudates was investigated using multivariate tools. Statistical analysis results show interaction effects between concentration and temperature on absorbance and L* values. Solid feed rate has a significant effect on absorbance only and screw speed showed least impact on both responses for the screening design. The optimum HME process conditions were confirmed by 4 independent studies to be 20% w/w of PRX, temperature 140 °C, screw speed 200 rpm and feed rate 6 g/min. The in-line UV-Vis system was used to assess the solubility of PRX in Kollidon® VA64 by measuring absorbance and L* values from 230 to 700 nm. Oversaturation was observed for PRX concentrations higher than 20% w/w. Oversaturation can be readily identified as it causes scattering in the visible range. This is observed by a shift of the baseline in the visible part of the spectrum. Extrudate samples were analyzed for degradation using off-line High-Performance Liquid Chromatography (HPLC) standard methods. Results from off-line experiments using differential scanning calorimetry (DSC), and X-ray diffraction (XRD) are also presented.
Collapse
|
19
|
Bostijn N, Hellings M, Van Der Veen M, Vervaet C, De Beer T. In-line UV spectroscopy for the quantification of low-dose active ingredients during the manufacturing of pharmaceutical semi-solid and liquid formulations. Anal Chim Acta 2018; 1013:54-62. [PMID: 29501092 DOI: 10.1016/j.aca.2018.02.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 01/08/2018] [Accepted: 02/02/2018] [Indexed: 11/21/2022]
Abstract
UltraViolet (UV) spectroscopy was evaluated as an innovative Process Analytical Technology (PAT) - tool for the in-line and real-time quantitative determination of low-dosed active pharmaceutical ingredients (APIs) in a semi-solid (gel) and a liquid (suspension) pharmaceutical formulation during their batch production process. The performance of this new PAT-tool (i.e., UV spectroscopy) was compared with an already more established PAT-method based on Raman spectroscopy. In-line UV measurements were carried out with an immersion probe while for the Raman measurements a non-contact PhAT probe was used. For both studied formulations, an in-line API quantification model was developed and validated per spectroscopic technique. The known API concentrations (Y) were correlated with the corresponding in-line collected preprocessed spectra (X) through a Partial Least Squares (PLS) regression. Each developed quantification method was validated by calculating the accuracy profile on the basis of the validation experiments. Furthermore, the measurement uncertainty was determined based on the data generated for the determination of the accuracy profiles. From the accuracy profile of the UV- and Raman-based quantification method for the gel, it was concluded that at the target API concentration of 2% (w/w), 95 out of 100 future routine measurements given by the Raman method will not deviate more than 10% (relative error) from the true API concentration, whereas for the UV method the acceptance limits of 10% were exceeded. For the liquid formulation, the Raman method was not able to quantify the API in the low-dosed suspension (0.09% (w/w) API). In contrast, the in-line UV method was able to adequately quantify the API in the suspension. This study demonstrated that UV spectroscopy can be adopted as a novel in-line PAT-technique for low-dose quantification purposes in pharmaceutical processes. Important is that none of the two spectroscopic techniques was superior to the other for both formulations: the Raman method was more accurate in quantifying the API in the gel (2% (w/w) API), while the UV method performed better for API quantification in the suspension (0.09% (w/w) API).
Collapse
|
20
|
Madarász L, Nagy ZK, Hoffer I, Szabó B, Csontos I, Pataki H, Démuth B, Szabó B, Csorba K, Marosi G. Real-time feedback control of twin-screw wet granulation based on image analysis. Int J Pharm 2018; 547:360-7. [PMID: 29879507 DOI: 10.1016/j.ijpharm.2018.06.003] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2018] [Revised: 05/12/2018] [Accepted: 06/02/2018] [Indexed: 11/24/2022]
Abstract
The present paper reports the first dynamic image analysis-based feedback control of continuous twin-screw wet granulation process. Granulation of the blend of lactose and starch was selected as a model process. The size and size distribution of the obtained particles were successfully monitored by a process camera coupled with an image analysis software developed by the authors. The validation of the developed system showed that the particle size analysis tool can determine the size of the granules with an error of less than 5 µm. The next step was to implement real-time feedback control of the process by controlling the liquid feeding rate of the pump through a PC, based on the real-time determined particle size results. After the establishment of the feedback control, the system could correct different real-life disturbances, creating a Process Analytically Controlled Technology (PACT), which guarantees the real-time monitoring and controlling of the quality of the granules. In the event of changes or bad tendencies in the particle size, the system can automatically compensate the effect of disturbances, ensuring proper product quality. This kind of quality assurance approach is especially important in the case of continuous pharmaceutical technologies.
Collapse
|
21
|
Park JB, Lee BJ, Kang CY, Repka MA. Process Analytical Quality Control of Tailored Drug Release Formulation Prepared via Hot-Melt Extrusion Technology. J Drug Deliv Sci Technol 2017; 38:51-58. [PMID: 29312469 DOI: 10.1016/j.jddst.2017.01.007] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The objective of the present study was to compare the influence of Eudragit® RS PO and RL PO blends on the release of water-soluble and insoluble drugs from hot-melt extruded formulations. In addition, we aimed to evaluate drug content uniformity and distribution by Fourier transform-infrared (FT-IR) chemical imaging. Theophylline (TP) and carbamazepine (CBZ) were selected as the water-soluble and insoluble model drugs, respectively. Eudragit® RS PO and RL PO were selected as the polymeric matrices. FT-IR chemical imaging clearly demonstrated the content uniformity and distribution for both drugs in the extrudates, which was confirmed by HPLC. Increasing the ratio of Eudragit® RL PO led to an increase in the in vitro drug release, whereas an increase in the ratio of Eudragit® RS PO sustained the drug release for up to 12 h. The hot-melt extrusion of TP and CBZ with varying ratios of Eudragit® RS PO and RL PO can be employed to tailor the drug release profiles. In this study, we demonstrated, for the first time, the use of FT-IR chemical imaging as a process analytical technique to determine the drug content uniformity and distribution. Our data correlated well with the results of HPLC analysis in the study of tailored drug release from the prepared hot-melt extruded formulation.
Collapse
Affiliation(s)
- Jun-Bom Park
- College of Pharmacy, Sahmyook University, Seoul, Republic of Korea
| | - Beom-Jin Lee
- College of Pharmacy, Ajou University, Suwon, Republic of Korea
| | - Chin-Yang Kang
- College of Pharmacy, Sahmyook University, Seoul, Republic of Korea
| | - Michael A Repka
- Department of Pharmaceutics & Drug Delivery, University of Mississippi, University, MS, USA.,Pii Center for Pharmaceutical Technology, School of Pharmacy, University of Mississippi, University, MS, USA
| |
Collapse
|
22
|
Pathak M, Dixit S, Muthukumar S, Rathore AS. Analytical characterization of in vitro refolding in the quality by design paradigm: Refolding of recombinant human granulocyte colony stimulating factor. J Pharm Biomed Anal 2016; 126:124-31. [PMID: 27206104 DOI: 10.1016/j.jpba.2016.05.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2015] [Revised: 04/26/2016] [Accepted: 05/01/2016] [Indexed: 10/21/2022]
Abstract
Protein based therapeutics dominate most pharmaceutical pipelines today. For a therapeutic product to be effective, it is important that it is in its native form as slight modifications have been known to result in significantly different performance in the clinic. When expressed in hosts such as Escherichia coli, formation of inactive insoluble aggregates of proteins popularly known as inclusion bodies occurs in most cases. This necessitates the need for in vitro refolding to generate the native (and active) form of the therapeutic protein. This paper aims to provide an approach to generate a deeper understanding of refolding of a therapeutic protein and then to use it for its optimal production commercially. Recombinant human granulocyte colony stimulating factor has been chosen as the model protein. Seven orthogonal analytical tools have been used to elucidate the refolding process. By strategically using these tools protein refolding has been segregated into a series of well-defined sequence of events, starting from the unfolded random coil and ending with the uniquely folded metastable state. The study also suggests the choice of tools that can be used to monitor each event. We believe that this paper successfully demonstrates an approach to generate deeper understanding of the protein refolding process as per the expectations laid out in the Quality by Design paradigm.
Collapse
Affiliation(s)
- Mili Pathak
- Department of Chemical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, India
| | - Shruti Dixit
- Department of Chemical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, India
| | - S Muthukumar
- Department of Chemical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, India
| | - Anurag S Rathore
- Department of Chemical Engineering, Indian Institute of Technology, HauzKhas, New Delhi, India.
| |
Collapse
|
23
|
Wahl PR, Fruhmann G, Sacher S, Straka G, Sowinski S, Khinast JG. PAT for tableting: inline monitoring of API and excipients via NIR spectroscopy. Eur J Pharm Biopharm 2014; 87:271-8. [PMID: 24705126 DOI: 10.1016/j.ejpb.2014.03.021] [Citation(s) in RCA: 77] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2014] [Revised: 03/24/2014] [Accepted: 03/27/2014] [Indexed: 10/25/2022]
Abstract
This paper describes the application and implementation of inline NIR spectroscopy in an industrial tablet press. The content uniformity of a powder was analyzed via a NIR probe mounted on the feed frame. A PLS model with four latent variables (R(2)=0.97, Q(2)=0.95) was developed for the Active Pharmaceutical Ingredient (API) and two main excipients (EX1, EX2), according to the mixture DoE. The RMSEP corresponded to the relative errors of 2.7% for API, 1.7% for EX1 and 2.6% for EX2, compared to the nominal formulation. Transfer of the model, from the lab to an inline setup for manufacturing was achieved using local centering. There was a good agreement between the results of inline NIR and drawn tablets analyzed via UV-Vis. Notably, NIR indicated stochastic segregation behavior of the powder toward the end of the process, which was confirmed by the UV-Vis analysis. The outcome of our work was related to the recently published Ph. Eur. chapter 2.9.47 "Demonstration of uniformity of dosage units using large sample sizes".
Collapse
Affiliation(s)
- Patrick R Wahl
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
| | - Georg Fruhmann
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
| | - Stephan Sacher
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
| | | | | | - Johannes G Khinast
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Institute for Process and Particle Engineering, Graz University of Technology, Graz, Austria.
| |
Collapse
|
24
|
Schaefer C, Clicq D, Lecomte C, Merschaert A, Norrant E, Fotiadu F. A Process Analytical Technology (PAT) approach to control a new API manufacturing process: development, validation and implementation. Talanta 2013; 120:114-25. [PMID: 24468350 DOI: 10.1016/j.talanta.2013.11.072] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2013] [Revised: 11/19/2013] [Accepted: 11/26/2013] [Indexed: 10/26/2022]
Abstract
Pharmaceutical companies are progressively adopting and introducing Process Analytical Technology (PAT) and Quality-by-Design (QbD) concepts promoted by the regulatory agencies, aiming the building of the quality directly into the product by combining thorough scientific understanding and quality risk management. An analytical method based on near infrared (NIR) spectroscopy was developed as a PAT tool to control on-line an API (active pharmaceutical ingredient) manufacturing crystallization step during which the API and residual solvent contents need to be precisely determined to reach the predefined seeding point. An original methodology based on the QbD principles was designed to conduct the development and validation of the NIR method and to ensure that it is fitted for its intended use. On this basis, Partial least squares (PLS) models were developed and optimized using chemometrics methods. The method was fully validated according to the ICH Q2(R1) guideline and using the accuracy profile approach. The dosing ranges were evaluated to 9.0-12.0% w/w for the API and 0.18-1.50% w/w for the residual methanol. As by nature the variability of the sampling method and the reference method are included in the variability obtained for the NIR method during the validation phase, a real-time process monitoring exercise was performed to prove its fit for purpose. The implementation of this in-process control (IPC) method on the industrial plant from the launch of the new API synthesis process will enable automatic control of the final crystallization step in order to ensure a predefined quality level of the API. In addition, several valuable benefits are expected including reduction of the process time, suppression of a rather difficult sampling and tedious off-line analyses.
Collapse
Affiliation(s)
- Cédric Schaefer
- UCB Pharma, Analytical Development Chemicals, Avenue de l'Industrie, 1420 Braine-l'Alleud, Belgium; Institut des Sciences Moléculaires de Marseille, CNRS, UMR 7313, École Centrale Marseille, Aix Marseille Université, Avenue Escadrille Normandie-Niemen, Case A62, 13397 Marseille cedex 20, France.
| | - David Clicq
- UCB Pharma, Analytical Development Chemicals, Avenue de l'Industrie, 1420 Braine-l'Alleud, Belgium
| | - Clémence Lecomte
- UCB Pharma, Chemical Process Development, Avenue de l'Industrie, 1420 Braine-l'Alleud, Belgium
| | - Alain Merschaert
- UCB Pharma, Chemical Process Development, Avenue de l'Industrie, 1420 Braine-l'Alleud, Belgium
| | - Edith Norrant
- UCB Pharma, Innovation & Technology Development, Avenue de l'Industrie, 1420 Braine-l'Alleud, Belgium
| | - Frédéric Fotiadu
- Institut des Sciences Moléculaires de Marseille, CNRS, UMR 7313, École Centrale Marseille, Aix Marseille Université, Avenue Escadrille Normandie-Niemen, Case A62, 13397 Marseille cedex 20, France
| |
Collapse
|
25
|
Wahl PR, Treffer D, Mohr S, Roblegg E, Koscher G, Khinast JG. Inline monitoring and a PAT strategy for pharmaceutical hot melt extrusion. Int J Pharm 2013; 455:159-68. [PMID: 23911343 DOI: 10.1016/j.ijpharm.2013.07.044] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2013] [Revised: 07/15/2013] [Accepted: 07/17/2013] [Indexed: 10/26/2022]
Abstract
Implementation of continuous manufacturing in the pharmaceutical industry requires tight process control. This study focuses on a PAT strategy for hot melt extrusion of vegetable calcium stearate (CaSt) as matrix carrier and paracetamol as active pharmaceutical ingredient (API). The extrusion was monitored using in-line near-infrared (NIR) spectroscopy. A NIR probe was located in the section between the extrusion screws and the die, using a novel design of the die channel. A chemometric model was developed based on premixes at defined concentrations and was implemented in SIPAT for real time API concentration monitoring. Subsequently, step experiments were performed for different API concentrations, screw speeds and screw designs. The predicted API concentration was in good agreement with the pre-set concentrations. The transition from one API plateau to another was a smooth curve due to the mixing behaviour of the extruder. The accuracy of the model was confirmed via offline HPLC analysis. The screw design was determined as the main influential factor on content uniformity (CU). Additionally the influence of multiple feeders had a significant impact on CU. The results demonstrate that in-line NIR measurements is a powerful tool for process development (e.g., mixing characterization), monitoring and further control strategies.
Collapse
Affiliation(s)
- Patrick R Wahl
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria
| | | | | | | | | | | |
Collapse
|